hydroxyurea plus didanosine as maintenance therapy after 1 year on highly active antiretroviral therapy [letter]

NLM AIDSLINE Hydroxyurea plus didanosine as maintenance therapy after 1 year on highly active antiretroviral therapy [letter] Barreiro P; de Mendoza C; Soriano V; Gonzalez-Lahoz J
June 30, 2000

AIDS. 2000 Jan 28;14(2):207-8. Unique Identifier : AIDSLINE MED/20170589 LETTER JOURNAL ARTICLE Anti-HIV Agents/THERAPEUTIC USE Didanosine/THERAPEUTIC USE Drug Therapy, Combination Enzyme Inhibitors/THERAPEUTIC USE Human Hydroxyurea/THERAPEUTIC USE HIV Infections/DRUG THERAPY Palliative Care Viremia

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 ARIZONA: Routine Skin Testing Available Again at Tuberculosis Clinic Starting May 20 NORTH DAKOTA: Officials: 26 Tuberculosis Cases from Grand Forks Outbreak AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common CANADA: Nunavut Uses Comic Book to Do Sex Education NEW HAMPSHIRE: State Health Officials Urge Hepatitis Testing UNITED STATES: Hepatitis C Testing for People Born Between 1945 and 1965 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common CALIFORNIA: Giants, Nonprofit Mark 20 Years of AIDS Awareness TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Recent Events Antiretroviral regimen associated with less virological failure among HIV-infected children PENNSYLVANIA: How a Home for People Living with HIV/AIDS in Manheim Township Has Evolved over 20 Years Vieillir avec le VIH, un nouveau défi pour 10.000 personnes de plus de 60 ans Gilead Receives Complete Response Letters from U.S. Food and Drug Administration for Elvitegravir and Cobicistat Synthetic derivatives of THC may weaken HIV-1 infection to enhance antiviral therapies UCLA study suggests potential therapy for HIV ILLINOIS: AIDS Legal Council of Chicago Marks 25 Years of Service
Information in this article was accurate in June 30, 2000. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.